Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. (Q47561710)

4 February 2018

title

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. (English)

1 reference

4 February 2018

author

Børge G. Nordestgaard

19

Børge G Nordestgaard

1 reference

4 February 2018

Nora Pashayan

31

0 references

Manuel R. Teixeira

Manuel R Teixeira

53

0 references

Hermann Brenner

Hermann Brenner

42

0 references

Verena Zuber

Verena Zuber

4

0 references

Agnieszka Michael

Agnieszka Michael

57

0 references

Paul D P Pharoah

30

Paul Pharoah

1 reference

4 February 2018

Jyotsna Batra

50

0 references

Rosalind Eeles

Rosalind A Eeles

7

0 references

Cezary Cybulski

38

Cezary Cybulski

1 reference

4 February 2018

32

Kay-Tee Khaw

1 reference

4 February 2018

12

Kenneth Muir

1 reference

4 February 2018

8

Douglas F Easton

1 reference

4 February 2018

16

Johanna Schleutker

1 reference

4 February 2018

61

Ole A Andreassen

1 reference

4 February 2018

62

Anders M Dale

1 reference

4 February 2018

13

Henrik Grönberg

1 reference

4 February 2018

52

Amanda Spurdle

1 reference

4 February 2018

27

David E Neal

1 reference

4 February 2018

Radka Kaneva

48

Radka Kaneva

1 reference

4 February 2018

Ruth Travis

26

Ruth C Travis

1 reference

4 February 2018

Judith Clements

51

Judith A Clements

1 reference

4 February 2018

Andrzej M. Kierzek

58

Andrzej Kierzek

1 reference

4 February 2018

Zsofia Kote-Jarai

9

ZSofia Kote-Jarai

1 reference

4 February 2018

Dominika Wokolorczyk

39

Dominika Wokolorczyk

1 reference

4 February 2018

Adam S Kibel

37

Adam S Kibel

1 reference

4 February 2018

Jenny L Donovan

28

Jenny L Donovan

1 reference

4 February 2018

Wojciech Kluźniak

40

Wojciech Kluzniak

1 reference

4 February 2018

Sune G. Nielsen

20

Sune F Nielsen

1 reference

4 February 2018

Teuvo L Tammela

18

Teuvo Lj Tammela

1 reference

4 February 2018

Thomas A Sellers

46

Thomas A Sellers

1 reference

4 February 2018

Tyler M Seibert

1

Tyler M Seibert

1 reference

4 February 2018

Lisa Cannon-Albright

41

Lisa Cannon-Albright

1 reference

4 February 2018

Ian G Mills

60

Ian G Mills

1 reference

4 February 2018

Freddie Hamdy

29

Freddie C Hamdy

1 reference

4 February 2018

Markus Aly

15

Markus Aly

1 reference

4 February 2018

Ali Amin Al Olama

10

Ali Amin Al Olama

1 reference

4 February 2018

Chavdar Slavov

47

Chavdar Slavov

1 reference

4 February 2018

Maren Weischer

21

Maren Weischer

1 reference

4 February 2018

Manuel Luedeke

35

Manuel Luedeke

1 reference

4 February 2018

Kathleen Herkommer

36

Kathleen Herkommer

1 reference

4 February 2018

Sofia Maia

55

Sofia Maia

1 reference

4 February 2018

Vanio Mitev

49

Vanio Mitev

1 reference

4 February 2018

Sara Benlloch Garcia

11

Sara Benlloch Garcia

1 reference

4 February 2018

Tim Keys

25

Tim J Key

1 reference

4 February 2018

Walther Vogel

34

Walther Vogel

1 reference

4 February 2018

Hardev Pandha

56

Hardev Pandha

1 reference

4 February 2018

Chun Chieh Fan

2

Chun Chieh Fan

1 reference

4 February 2018

J Kellogg Parsons

6

J Kellogg Parsons

1 reference

4 February 2018

Fredrik Wiklund

14

Fredrik Wiklund

1 reference

4 February 2018

Csilla Sipeky

17

Csilla Sipeky

1 reference

4 February 2018

Rasmus Bisbjerg

22

Rasmus Bisbjerg

1 reference

4 February 2018

Katarina Cuk

43

Katarina Cuk

1 reference

4 February 2018

Kai-Uwe Saum

44

Kai-Uwe Saum

1 reference

4 February 2018

David S Karow

59

David S Karow

1 reference

4 February 2018

author name string

Yunpeng Wang

3

1 reference

4 February 2018

Roshan Karunamuni

5

1 reference

4 February 2018

M Andreas Røder

23

1 reference

4 February 2018

Peter Iversen

24

1 reference

4 February 2018

Christiane Maier

33

1 reference

4 February 2018

Jong Y Park

45

1 reference

4 February 2018

Paula Paulo

54

1 reference

4 February 2018

PRACTICAL Consortium*

63

1 reference

4 February 2018

language of work or name

English

0 references

publication date

10 January 2018

1 reference

4 February 2018

published in

The BMJ

1 reference

4 February 2018

volume

360

1 reference

4 February 2018

page(s)

j5757

1 reference

4 February 2018

Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Developing and evaluating polygenic risk prediction models for stratified disease prevention

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

22 May 2018

Cancer statistics, 2016

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Global cancer statistics, 2012

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Overdiagnosis and overtreatment of prostate cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

The genetic epidemiology of prostate cancer and its clinical implications

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Prostate cancer: ESMO Consensus Conference Guidelines 2012

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Baseline prostate-specific antigen testing at a young age.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

American Cancer Society guideline for the early detection of prostate cancer: update 2010

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

22 May 2018

Cancer statistics, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

22 May 2018

Cancer statistics, 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Prostate Cancer, Version 1.2016.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Genetic variants associated with predisposition to prostate cancer and potential clinical implications

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Personalized prostate cancer screening: improving PSA tests with genomic information.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

PSA-detected prostate cancer and the potential for dedifferentiation--estimating the proportion capable of progression

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

A graphical device to represent the outcomes of a logistic regression analysis.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759091

Polygenes, risk prediction, and targeted prevention of breast cancer

14 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29321194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.J5757

1 reference

4 February 2018

release_zztj76p67zgirefimd5a2cl65u

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zztj76p67zgirefimd5a2cl65u

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

5759091

1 reference

4 February 2018

PubMed ID

29321194

1 reference

4 February 2018